8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): July 8, 2010

RENHUANG PHARMACEUTICALS, INC.

(Exact name of Registrant as Specified in its Charter)

Nevada	0-24512	84-1273503
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

No. 281, Taiping Road, Taiping District

Harbin, Heilongjiang Province, 150050

(Address of Principal Executive Offices)

Registrant’s telephone number, including area code:  86-451-5762-0378

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 1.01. Entry into a Material Definitive Agreement.

On July 8, 2010, Renhuang Pharmaceuticals, Inc. (the “Company”) executed an Acquisition Agreement (the “Agreeement”) with Yichun Red Star Forest Bureau of Heilongjiang Province (the “Forest Bureau”) for indefinite exclusive access to 100,000 acres of wild Siberian Ginseng in Heilongjiang Province. Siberian Ginseng is a plant with medically-established anti-depressant and mood regulation qualities and is also an active ingredient in the Company’s market-leading line of all-natural anti-depressant medications. Under the terms of the Agreement, Renhuang will be granted permanent exclusive rights to purchase the wild Siberian Ginseng grown on 100,000 acres.  The Siberian Ginseng plant yield is expected to amount to an estimated 500 tons annually. The Siberian Ginseng fields will be maintained and harvested by personnel supervised by the Forest Bureau and the Company will pay a lower than prevailing fair market price for the Siberian Ginseng harvested. Renhuang will be responsible for continued maintenance and protection of wild resources to make this area a professional Siberian Ginseng base. In addition to generating income for the Forest Bureau, this resource base will provide employment opportunities for local farmers.

Additional information regarding the foregoing changes is contained in the Acquisition Agreement attached hereto as Exhibit 10.6 and the press release attached hereto as Exhibit 991.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

(d) EXHIBITS.

10.6	Acquisition Agreement, with Yichun Red Star Forest Bureau, of Acanthopanax Resources
99.1	Press Release dated July 8, 2010

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	RENHUANG PHARMACEUTICALS, INC.
Date: July 14, 2010	By:	/s/ Shaoming Li
		Shaoming Li
		Chief Executive Officer

EX-10.6

The Acquisition Agreement of Acanthopanax（Siberian Ginseng） Resources

PARTY A: Hongxing Forestry Bureau

PARTY B: Harbin Renhuang Pharmaceuticals, Inc.

For the purpose of the strategy “The ecology can establish the forestry zone and the industry can flourish the forestry zone”, the parties is based on the technical and capital advantage of Renhuang and the acanthopanax wild recourses from Hongxing Forestry Bureau to establish the largest acanthopanax industrial system , promote the sustainable development to make the forestry zone replace industry and keep Renhuang realizing corporate business strategies, the Parties hereby agree as follows:

Article I The Cooperation Information

1.   Party A need to delimit 100,000 acres of wild acanthopanax forest land for party B to purchase natural resources here.

2.   Party B should be responsible for maintaining and scientific managing the wild acanthopanax resources in the forestry zone and finally shaping a professional acanthopanax resource base by the scientific management.

3.   The annual resource picking amount is up to about 500 tons in this zone.

4.   The follow-up cooperation in development between the parties will be based on the actual basis and the parties will decide to sign the successor agreement as the discussion later.

Article II The Rights and Obligations of Party A

1. Party A should make sure all of the acanthopanax that the farmer picked in the definitive zone of Hongxing Forestry Bureau  to be sold to the Party B.

2. Party A should keep the exclusive resource purchasing right for Part B. The Party A can’t sell it to others without the permission of Party B.

3. Party A should be responsible for keeping and looking after the other natural resources except for the acanthopanax resources.

Article III The Rights and Obligations of Party B

1. Party B should be responsible for integrating and maintaining the acanthopanax resources and totally purchase the picking acanthopanax resources, which were picked by the local farmer.

2. Party B need to offer job opportunities for the staff in the Hongxing Forestry Bureau and creat profits for the local people there.

3.  Party B should try its best to improve the economic development in the area of Hongxing Forestry Burea and contribute to them.

 Article IIVPayment Method

1. Party B should purchase the acanthopanax resources as the price that is little lower than the market price (or based on the actural discussion with the Bureau and local people).

2. Party B should pay Party A or the local farmer in the method of telegraphic transfer, transfer accounts or in cash as the discussed price between the parties.

Article V Term

The term of this agreement is permanent.

Article VI Applicable Law

1.   The formation, effective, interpretation of agreement is subject  to Contract Law and Corporate Law of the Peoples Republic of China.

2.   Any dispute between the parties should be solved upon the discussion between each other. If it can’t be solved as discussion, the parties have the right to institute legal proceedings to the court.

Article VII  The Modification, Change and Supplement of Agreement

The Modification, Change and Supplement of this Agreement need to be consensus as discussion between the parties.

Article VIII Special Convention

Any information about the agreement to be disclosed should be permitted by Party B in written approval, except for the  information upon the legal rules.

Article IX The Effective of Agreement  

This agreement is in duplicate. Part A and Part B each have one copy. The copies of it should be the same rights as the original.

Article X Miscellaneous

Any unaccomplished matter about this agreement will be   added to supplementary agreement as discussion between the parties later.

July 8 2010

EX-99.1

Company Contact:	CCG Investor Relations:
Renhuang Pharmaceuticals, Inc.	Mr. Mark Collinson, Partner
Ms. Portia Tan, IR Contact	Phone: +1-310-954-1343 (Los Angeles)
Tel: 86-451-8260-2162	Email: mark.collinson@ccgir.com
Email: ir@renhuang.com	Website: www.ccgirasia.com
	Mr. Crocker Coulson, President
	Phone: +1-646-213-1915 (New York)
	Email: crocker.coulson@ccgir.com

For Immediate Release

Renhuang Signs Exclusive Purchase Agreement for Siberian Ginseng

Harbin, China – July 9, 2010 – Renhuang Pharmaceuticals, Inc. ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that on July 8, 2010, the Company signed an Acquisition Agreement (the “Agreement”) with Yichun Red Star Forest Bureau of Heilongjiang Province (“the Forest Bureau”) for indefinite exclusive access to 100,000 acres of wild Siberian Ginseng in Heilongjiang Province. Siberian Ginseng is a plant with medically-established anti-depressant and mood regulation qualities and is also an active ingredient in the Company’s market-leading line of all-natural anti-depressant medications.

Under the terms of the Agreement, Renhuang will be granted permanent exclusive rights to purchase the wild Siberian Ginseng grown on 100,000 acres., The Siberian Ginseng plant yield is expected to amount to an estimated 500 tons annually. The Siberian Ginseng fields will be maintained and harvested by personnel supervised by the Forest Bureau and the Company will pay a lower than prevailing fair market price for the Siberian Ginseng harvested. Renhuang will be responsible for continued maintenance and protection of wild resources to make this area a professional Siberian Ginseng base that produces additional Ginseng. In addition to generating income for the Forest Bureau, this resource base will provide employment opportunities for local farmers.

“We are excited about securing exclusive access to the world’s finest quality wild Siberian Ginseng,” said Mr. Shaoming Li, Chairman and CEO of Renhuang. “It is also a great honor to work on a project with Yichun Red Star Forest Bureau to assist in the economic development of the region and improve the cultivation of this precious natural resource. This Agreement provides us a reliable and abundant supply of Siberian Ginseng at an attractive price, resulting in a significant competitive advantage in the market.”

ABOUT RENHUANG PHARMACEUTICALS, INC.

Renhuang Pharmaceuticals, Inc. is engaged in the research, development, manufacturing, and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines (“TCM”), in the People's Republic of China.  All of the Company’s products are produced at its three GMP-certified production facilities in Ah City, Dongfanghong and Qingyang. The Company distributes its botanical anti-depression and nerve-regulation products, biopharmaceutical products, and botanical antibiotic and OTC TCMs through its network of over 3,000 distributors and over 70 sales centers across 24 provinces in China.  Company Website: www.renhuang.com.

Safe Harbor Statement

This press release contains certain statements that may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are based upon management’s beliefs, assumptions and expectations of the Company’s future operations and economic performance, taking into account the information currently available to management. These statements are not statements of historical fact. Forward-looking statements involve risks and uncertainties, some of which are not currently known that may cause actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial condition expressed or implied in any forward-looking statements. These forward-looking statements are based on current plans and expectations and are subject to a number of uncertainties including, but not limited to, the Company's competitive advantages as a result of the acquisition agreement with Yichun Red Star Forest Bureau of Heilongjiang Province, ability to manage expansion of its operations effectively, and other factors detailed in the Company’s annual report on Form 10-K and other filings with the Securities and Exchange Commission.  The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented herein.

###